140 related articles for article (PubMed ID: 18077847)
1. Cost-effectiveness of alternative outpatient pelvic inflammatory disease treatment strategies.
Smith KJ; Ness RB; Wiesenfeld HC; Roberts MS
Sex Transm Dis; 2007 Dec; 34(12):960-6. PubMed ID: 18077847
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of five different antibiotic regimens for the treatment of uncomplicated Chlamydia trachomatis cervicitis.
Nuovo J; Melnikow J; Paliescheskey M; King J; Mowers R
J Am Board Fam Pract; 1995; 8(1):7-16. PubMed ID: 7701965
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic therapy for pelvic inflammatory disease.
Savaris RF; Fuhrich DG; Duarte RV; Franik S; Ross J
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010285. PubMed ID: 28436019
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial.
Ness RB; Trautmann G; Richter HE; Randall H; Peipert JF; Nelson DB; Schubeck D; McNeeley SG; Trout W; Bass DC; Soper DE
Obstet Gynecol; 2005 Sep; 106(3):573-80. PubMed ID: 16135590
[TBL] [Abstract][Full Text] [Related]
5. Improvement in the clinical cure rate of outpatient management of pelvic inflammatory disease following a change in therapy.
Piyadigamage A; Wilson J
Sex Transm Infect; 2005 Jun; 81(3):233-5. PubMed ID: 15923292
[TBL] [Abstract][Full Text] [Related]
6. Pelvic inflammatory disease in the adolescent: understanding diagnosis and treatment as a health care provider.
Woods JL; Scurlock AM; Hensel DJ
Pediatr Emerg Care; 2013 Jun; 29(6):720-5. PubMed ID: 23714759
[TBL] [Abstract][Full Text] [Related]
7. Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group.
Martens MG; Gordon S; Yarborough DR; Faro S; Binder D; Berkeley A
South Med J; 1993 Jun; 86(6):604-10. PubMed ID: 8506477
[TBL] [Abstract][Full Text] [Related]
8. Hospitalization for pelvic inflammatory disease: a cost-effectiveness analysis.
Smith KJ; Ness RB; Roberts MS
Sex Transm Dis; 2007 Feb; 34(2):108-12. PubMed ID: 16794559
[TBL] [Abstract][Full Text] [Related]
9. Treating pelvic inflammatory disease with doxycycline and metronidazole or penicillin and metronidazole.
Heinonen PK; Teisala K; Punnonen R; Aine R; Lehtinen M; Miettinen A; Paavonen J
Genitourin Med; 1986 Aug; 62(4):235-9. PubMed ID: 3089909
[TBL] [Abstract][Full Text] [Related]
10. Fecundity and morbidity following acute pelvic inflammatory disease treated with doxycycline and metronidazole.
Heinonen PK; Leinonen M
Arch Gynecol Obstet; 2003 Oct; 268(4):284-8. PubMed ID: 14504870
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.
Ness RB; Soper DE; Holley RL; Peipert J; Randall H; Sweet RL; Sondheimer SJ; Hendrix SL; Amortegui A; Trucco G; Songer T; Lave JR; Hillier SL; Bass DC; Kelsey SF
Am J Obstet Gynecol; 2002 May; 186(5):929-37. PubMed ID: 12015517
[TBL] [Abstract][Full Text] [Related]
12. [Ciprofloxacin/metronidazole vs. cefoxitin/doxycycline: comparison of two therapy schedules for treatment of acute pelvic infection].
Fischbach F; Deckardt R; Graeff H
Geburtshilfe Frauenheilkd; 1994 Jun; 54(6):337-40. PubMed ID: 8088489
[TBL] [Abstract][Full Text] [Related]
13. Status of adolescent pelvic inflammatory disease management in the United States.
Trent M
Curr Opin Obstet Gynecol; 2013 Oct; 25(5):350-6. PubMed ID: 24018871
[TBL] [Abstract][Full Text] [Related]
14. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
[TBL] [Abstract][Full Text] [Related]
15. A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease.
Heinonen PK; Teisala K; Miettinen A; Aine R; Punnonen R; Grönroos P
Scand J Infect Dis Suppl; 1989; 60():66-73. PubMed ID: 2756353
[TBL] [Abstract][Full Text] [Related]
16. Treatment of pelvic inflammatory disease.
Cunha BA
Clin Pharm; 1990 Apr; 9(4):275-85. PubMed ID: 2184973
[TBL] [Abstract][Full Text] [Related]
17. Design of the PID Evaluation and Clinical Health (PEACH) Study.
Ness RB; Soper DE; Peipert J; Sondheimer SJ; Holley RL; Sweet RL; Hemsell DL; Randall H; Hendrix SL; Bass DC; Kelsey SF; Songer TJ; Lave JR
Control Clin Trials; 1998 Oct; 19(5):499-514. PubMed ID: 9741869
[TBL] [Abstract][Full Text] [Related]
18. Adherence to oral therapies in pelvic inflammatory disease.
Dunbar-Jacob J; Sereika SM; Foley SM; Bass DC; Ness RB
J Womens Health (Larchmt); 2004 Apr; 13(3):285-91. PubMed ID: 15130257
[TBL] [Abstract][Full Text] [Related]
19. A randomised comparison of strategies for reducing infective complications of induced abortion.
Penney GC; Thomson M; Norman J; McKenzie H; Vale L; Smith R; Imrie M
Br J Obstet Gynaecol; 1998 Jun; 105(6):599-604. PubMed ID: 9647149
[TBL] [Abstract][Full Text] [Related]
20. Outpatient antibiotics for pelvic inflammatory disease.
Ross JD
BMJ; 2001 Feb; 322(7281):251-2. PubMed ID: 11157512
[No Abstract] [Full Text] [Related]
[Next] [New Search]
